DFDavid Ferreira

David Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Ferreira has a total of 184 co-authors. Here are the top co-authors by number of shared publications:

  • Nicholas Collins

    Cardiology Department, John Hunter Hospital, Hunter New England Local Health District, Newcastle, Australia (D.F., N.C., A.B.).

    8 shared publications
  • Andrew Boyle

    Cardiovascular Department, John Hunter Hospital, Newcastle, New South Wales, Australia; School of Medicine and Public Health, University of Newcastle, New South Wales, Australia; Hunter Medical Research Institute, Newcastle, New South Wales, Australia

    6 shared publications
  • Bradley Wilsmore

    Cardiovascular Department, John Hunter Hospital, Newcastle, New South Wales, Australia; School of Medicine and Public Health, University of Newcastle, New South Wales, Australia

    5 shared publications
  • James Leitch

    Cardiovascular Department, John Hunter Hospital, Newcastle, New South Wales, Australia; School of Medicine and Public Health, University of Newcastle, New South Wales, Australia; Hunter Medical Research Institute, Newcastle, New South Wales, Australia

    4 shared publications
  • Lloyd Butel-Simoes

    Cardiovascular Department, John Hunter Hospital, Newcastle, New South Wales, Australia

    4 shared publications
  • Maged William

    Cardiology Department, Gosford Hospital, Central Coast Local Health District, Australia (A.C.B., W.M., P.M., E.C., E.R., N.H., A.P., S.L.S., A.K., T.K., A.H., R.S., K.S., A.M., M.P., M.I., M.W., P.J., T.J.F.).

    4 shared publications

Latest Publications

  • Open Access

    Safety, Efficacy and Cost of Same-Day Discharge after Pulsed Field Ablation for Atrial Fibrillation: A Sub-study of the Multicentre SENTINEL Registry

    by Francis J Ha, James Sindone, Sohaib Virk, Austin Chin Chwan Ng, Chi Kin Law, Stephen Brienesse, Alexis Puvrez, David Ferreira, Bruno Scardamaglia Kistler, Julia Zhou, et al.

  • Arctic Front Advance Versus POLARx Cryoablation System for Pulmonary Vein Isolation in Patients With Atrial Fibrillation: A Single-Center Randomized Controlled Trial

    by David Ferreira, Jovita Dwivedi, Stephen Brienesse, Michael M. Malaty, Kerissa Govender, Natasha Trevaskis, Byron Hughes, Aaron L. Sverdlov, Nicholas Collins, Andrew Boyle, et al.

  • Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial

    by Adam C. Bland, William Meere, Philopatir Mikhail, Eunice Chuah, Eleanor Redwood, David Ferreira, Nicklas Howden, Adam Perkovic, Samantha L. Saunders, Amy Kelty, et al.

    BACKGROUND: The 1.5 mm Baby J hydrophilic narrow J-tipped wire is a development of the standard 0.035” 3-mm J-tipped peripheral guidewire, designed to improve efficiency of transradial coronary procedures by safely navigating small caliber radial arteries to the aorta. There is currently a lack of evidence comparing the procedural success and safety of different peripheral guidewires used in transradial cardiac procedures. We compared the efficacy and safety of a narrow J-tipped hydrophilic 0.035” wire (intervention, Radifocus Baby J guidewire; TERUMO Co, Tokyo, Japan) versus a standard fixed-core 0.035” J wire (control). METHODS: Investigator-initiated, blinded, Australian, multicenter randomized trial in patients undergoing clinically indicated coronary angiography or percutaneous coronary intervention. Patients were randomized 1:1 to use either the control guidewire or the intervention guidewire. The primary end point (technical success) was defined as gaining aortic root access with the randomized guidewire. RESULTS: In all, 330 patients were randomized between October 2022 and June 2023 (median age was 69 years, 36% were female, and body mass index was 29 kg/m 2 ). The primary end point was achieved more frequently in the intervention group (96% versus 84%; absolute risk reduction 12% [95% CI, 5.7–18.3]; P P P =0.024). The main mechanisms of failure using the control wire were radial artery spasm (15/26; 57%) and subclavian tortuosity (5/26; 19.2%). There were no differences in overall procedure times, major adverse cardiovascular events, or vascular complications between guidewires. CONCLUSIONS: A narrow 1.5 mm J-tipped hydrophilic guidewire resulted in greater technical success and reduced fluoroscopy time compared with the standard 3-mm J-tipped nonhydrophilic guidewire. The guidewire is safe and demonstrated key incremental benefits for the transradial approach, particularly in women. REGISTRATION: URL: https://www.anzctr.org.au/ ; Unique identifier: ACTRN12622001557729.


  • Manual Chest PRESSURE During Direct Current Cardioversion for Atrial Fibrillation

    by David Ferreira, Philopatir Mikhail, Joyce Lim, Max Ray, Jovita Dwivedi, Stephen Brienesse, Lloyd Butel-Simoes, William Meere, Adam Bland, Niklas Howden, et al.


  • Open Access

    Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial

    by David Ferreira, Jack Hardy, William Meere, Lloyd Butel-Simoes, Shanathan Sritharan, Max Ray, Matthew French, Michael McGee, Simon O’cOnnor, Nicholas Whitehead, et al.

    Background and Aims: Current guidelines recommend 6 h of solid food and 2 h of clear liquid fasting for patients undergoing cardiac procedures with conscious sedation. There are no data to support this practice, and previous single-centre studies support the safety of removing fasting requirements. The objective of this study was to determine the non-inferiority of a no-fasting strategy to fasting prior to cardiac catheterization procedures which require conscious sedation. Methods: This is a multicentre, investigator-initiated, non-inferiority, randomized trial conducted in Australia with a prospective open-label, blinded endpoint design. Patients referred for coronary angiography, percutaneous coronary intervention, or cardiac implantable electronic device (CIED)-related procedures were enrolled. Patients were randomized 1:1 to fasting as normal (6 h solid food and 2 h clear liquid) or no-fasting requirements (encouraged to have regular meals but not mandated to do so). Recruitment occurred from 2022 to 2023. The primary outcome was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia assessed with a Bayesian approach. Secondary outcomes included patient satisfaction score, new ventilation requirement (non-invasive and invasive), new intensive care unit admission, 30-day readmission, 30-day mortality, 30-day pneumonia. Results: A total of 716 patients were randomized with 358 in each group. Those in the fasting arm had significantly longer solid food fasting (13.2 vs. 3.0 h, Bayes factor >100, indicating extreme evidence of difference) and clear liquid fasting times (7.0 vs. 2.4 h, Bayes factor >100). The primary composite outcome occurred in 19.1% of patients in the fasting arm and 12.0% of patients in the no-fasting arm. The estimate of the mean posterior difference in proportions with credibility interval (CI) in the primary composite outcome was −5.2% (95% CI −9.6 to −.9), favouring no fasting. This result confirms the non-inferiority (posterior probability >99.5%) and superiority (posterior probability 99.1%) of no fasting for the primary composite outcome. The no-fasting arm had improved patient satisfaction scores with a posterior mean difference of 4.02 points (95% CI 3.36–4.67, Bayes factor >100). Secondary outcome events were observed to be similar. Conclusions: In patients undergoing cardiac catheterization and CIED-related procedures, no fasting was non-inferior and superior to fasting for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Patient satisfaction scores were significantly better with no fasting. This supports removing fasting requirements for patients undergoing cardiac catheterization laboratory procedures that require conscious sedation.


  • Open Access

    Manual Chest PRESSURE during Direct Current Cardioversion for Atrial Fibrillation: A Randomised Control Trial (PRESSURE-AF)

    by David Ferreira, Philopatir Mikhail, Joyce Lim, Max Ray, Jovita Dwivedi, Stephen Brienesse, Lloyd Butel-Simoes, William Meere, Adam Bland, Nicklas Howden, et al.

    Background: Direct current cardioversion is frequently used to return patients with atrial fibrillation (AF) to sinus rhythm. Chest pressure during cardioversion may improve the efficacy of cardioversion through decreasing transthoracic impedance and increasing cardiac energy delivery. We aimed to assess the efficacy and safety of upfront chest pressure during direct current cardioversion for atrial fibrillation with anterior-posterior pad positioning. Design, Setting and Participants: This was a multi-center, investigator-initiated, patient and analysis blinded, randomised clinical trial. Recruitment occurred from 2021 to 2023. Follow-up was until hospital discharge. Recruitment occurred across three centers in New South Wales, Australia. Inclusion criteria were age ≥18, referred for cardioversion for AF, and anticoagulation for three weeks or transoesophageal echocardiography excluding left atrial appendage thrombus. Exclusion criteria were other arrhythmias requiring cardioversion, such as atrial flutter and atrial tachycardia. Intervention and Outcomes: The intervention arm received chest pressure during cardioversion from the first shock. The primary efficacy outcome was total joules required per patient encounter. Secondary efficacy outcomes included first shock success, transthoracic impedance, cardioversion success and sinus rhythm at 30 minutes post cardioversion. Results: 311 patients were randomised, 153 to control and 158 to intervention. There was no difference in total joules applied per encounter in the control arm versus intervention arm (356.4 ± 301 vs 413.8 ± 347, P=0.25). There was no difference in first shock success, total shocks provided, average impedance and cardioversion success. Conclusions and Relevance: This study does not support the routine application of chest pressure for direct current cardioversion in atrial fibrillation. Reducing the complexity of cardioversion will improve the efficiency of the procedure for patients and healthcare systems. Funding: None to disclose Trial Registration: ACTRN12620001028998

  • Open Access

    QRS width variation as a marker of prognosis after CRT implantation: getting slimmer is getting better

    by D Ferreira, J Brito, P A Silva, P S Antonio, S C Pereira, B V Silva, C Oliveira, B Garcia, A M Martins, P M Raposo, et al.

    Introduction: Cardiac resynchronization therapy (CRT) is a major therapeutic tool in the management of patients with systolic heart failure. However, controversy remains regarding who will most benefit from this device. The aim of the present study was to evaluate the impact of QRS duration on echocardiographic response and clinical outcomes. Methods: We conducted a retrospective, observational, single-center study of patients submitted to CRT implantation. Only patients with electro and echocardiographic data on baseline and follow-up were included. CRT response was defined as an improvement of LVEF >10% or LVESV>5%. CRT superresponse was defined as an improvement of LVEF above the population 4th quartile (18%). Impact of QRS variables on CRT response was evaluated with ROC curve analysis. Clinical outcomes were defined as hospitalizations due to heart failure and all-cause mortality. Impact of QRS on clinical endpoints, response and superresponse was evaluated with survival analysis. Results: From a total of 654 pts a total of 245 fulfilled the inclusion criteria. (57,3%% female, mean age). Most of the pts had a non-ischemic etiology (61,5%) and atrial fibrillation was present in 29.4%. The QRS characteristics were the following, baseline: 162+21ms, follow-up 159+28ms, mean QRS variation: 3+29ms. CRT response occurred in 69% of the pts and superresponse in 26%. QRS variation is the best predictor of CRT response (AUC =0,66, 95%CI 0,58-0,74, p<0,001). Interestingly, a QRS reduction above 8ms presented the best accuracy (S:70%;E:57%) for response to CRT. On multivariate analysis, after adjustment for gender, atrial fibrillation and cardiopathy etiology, only a QRS reduction above 8ms (p 0.028, HR 1.974 CI (1.075-3.623) and lower baseline LVEF (p = 0.02, 95% CI 0.943 (0.909-0.979) were significant independent predictors of CRT superresponse. Additionally, a QRS reduction higher than 8ms was a protective factor for long-term clinical outcomes during follow-up (p<0.001 HR (2,445) 1,553 a 3,849) – fig.1. Conclusion: In pts with implanted CRT a reduction in QRS width, as small as 8ms, its a marker of improved LV function and a better clinical prognosis.

  • UCInvaders: Reusing a Game to Promote Physical Activity Among College Students

    by Miguel L. Pereira, Daniel Vieira, David Ferreira, Pedro Calhau, Paulo Menezes

    Despite the importance of physical activity in human health, there is a high percentage of people who do not exercise. Exergames are among the approaches aimed at fighting sedentary lifestyles, with particular success among the youth. We aim to develop an exergame suitable for college-aged students, focusing on mechanisms to promote the exercise of upper limbs and lower body, and on game elements to assure enjoyment and replayability. The game is intended to be easily accessible, to allow for implementation in a large community. A validation of our solution is presented, evaluating user experience, game enjoyment and physical activity perception.

  • Open Access

    Safety and care of no fasting prior to catheterization laboratory procedures: a non-inferiority randomized control trial protocol (SCOFF trial)

    by David Ferreira, Jack Hardy, Will Meere, Lloyd Butel-Simoes, Michael McGee, Nicholas Whitehead, Paul Healey, Tom Ford, Christopher Oldmeadow, John Attia, et al.

    Aims: Cardiac catheterization procedures are typically performed with local anaesthetic and proceduralist guided sedation. Various fasting regimens are routinely implemented prior to these procedures, noting the absence of prospective evidence, aiming to reduce aspiration risk. However, there are additional risks from fasting including patient discomfort, intravascular volume depletion, stimulus for neuro-cardiogenic syncope, glycaemic outcomes, and unnecessary fasting for delayed/cancelled procedures. Methods and results: This is an investigator-initiated, multicentre, randomized trial with a prospective, open-label, blinded endpoint (PROBE) assessment based in New South Wales, Australia. Patients will be randomized 1:1 to fasting (6 h solid food and 2 h clear liquids) or to no fasting requirements. The primary outcome will be a composite of hypotension, hyperglycaemia, hypoglycaemia, and aspiration pneumonia. Secondary outcomes will include patient satisfaction, contrast-induced nephropathy, new intensive care admission, new non-invasive or invasive ventilation requirement post procedure, and 30-day mortality and readmission. Conclusions: This is a pragmatic and clinically relevant randomised trial designed to compare fasting verse no fasting prior to cardiac catheterisation procedures. Routine fasting may not reduce peri-procedural adverse events in this setting.


  • Open Access

    The Prevalence of Iron Deficiency in Atrial Fibrillation: Low Hanging Fruit?

    by Bachar Alabdullah, David Ferreira, Erin Bourke, Harish Kamalanathan, Ibrahim Elashri, Kushal Porwal, Michael J. Tiller, Payal H. Gadre, Sarah Jones, Michael McGee

    Background and Objectives: Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide. The relationship between AF and iron deficiency is poorly understood. Materials and Methods: We conducted an observational study investigating the prevalence of iron deficiency in those with AF. Iron deficiency was defined by the American College of Cardiology (ACC) criteria for iron deficiency in heart failure. Results: Of 134 eligible subjects, 81 (60.4%) met the ACC definition of iron deficiency in heart failure. Those who were iron deficient were more likely to be female (OR 1.876, p = 0.005), have a history of diabetes mellitus (OR 3.085, p = 0.001) a history of stroke (OR 3.147, p = 0.016), and have higher CHA2DS2-VASc (p ≤ 0.0001) and Charlson Comorbidity Index scores (CCI) (p = 0.007). Conclusions: The prevalence of iron deficiency in those with AF appears high and warrants evaluation in a prospective study.